Sim&Cure is currently owned by Elaia Partners, through Elaia Delta Fund, since 2019.

When did Elaia Partners acquire Sim&Cure?

Elaia Partners acquired Sim&Cure in 2019 (active for 7 years).

Home/Companies/Biotech/Sim&Cure

Sim&Cure

Biotech·

France·Active·7yr hold

Sim&Cure is a life sciences company, headquartered in France.

Entry

2019

Hold

7yr

Status

Active

Est. EV

–

Investor

Elaia Partners

Key facts

HQFrance

SectorLife Sciences

Sim&Cure develops the medical software Sim&Size® to optimize the choice of endovascular devices for the treatment of cerebral aneurysm.…Read full notes

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

6 portfolio peers in Elaia Delta Fund

6 comparable biotech deals from other GPs

Start free

Already a member? Sign in

Data refreshed weekly · Sourced from public filings